Product Categories
| Country: | China |
|---|---|
| Tel: | 020-18102736 |
| Mobile: | 18102736234 |
| E-mail: | 2208093734@qq.com |
| QQ: | 3003984946 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Impurity I (isoproterenol) | C12H19NO3 | 28148-80-3 | Details |
| Impurity J | C13H21NO3 | 767223-03-0 | Details |
| Impurities of allopurinol 25 | C6H6N4O | 30129-57-8 | Details |
| Glucose acid impurity 13 | 34290-52-3 | Details |
| 3-Hydroxynaphthalene-2,7-disulfonic | C10H9NaO7S2 | 135-51-3 | Details |
| Cetirizine EP impurity B(deracemization) | C19H21ClN2O2 | 113740-61-7 | Details |
| noradrenaline bitartrate | C12H19NO10 | 110-65-8 | Details |
| Intermediate F of Flomoxef | C25H23ClF2N2O6S | 134237-56-2 | Details |
| Cefuroxime Sodium EP Impurity C | C15H15N3O6S | 69822-88-4 | Details |
| 4-Nitrobenzenesulfonamide | C6H6N2O4S | 6325-93-5 | Details |
| (18β,20α)-Glycyrrhizic acid | C42H62O16 | 118441-85-3 | Details |
| Ipratropium Bromide Impurity 22 | C18H25NO2 | 88607-15-2 | Details |
| Flusulfonamide API-R | C14H13F4N3O3S | 2421252-30-2 | Details |
| Faropenem finished product impurity 17 | C12H17NO6S | 1177767-30-4 | Details |
| Ethyl analogue 7-Chloro-3-ethyl-2H-1,2,4-Benzothiazine-1,1-dioxide | C9H9ClN2O2S | 1207-63-2 | Details |
| Xanomeline Impurity 6 | C15H25N3OS | 131986-66-8 | Details |
| Faropenem finished product impurity 2 | C12H17NO6S | 754152-74-4 | Details |
| Suzetrigine | C21H20F5N3O4 | 2649467-58-1 | Details |
| Faropenem finished product impurity 24 | C6H16OSi | 18173-64-3 | Details |
| Roxithromycin EP Impurity G | C42H78N2O16 | 425365-64-6 | Details |
| NEU1130-VST-IM2 reference standard | C23H27N5O3 | 952652-79-8 | Details |
| 5-(4-Bromophenyl)-4,6-dichloropyrimidine | C10H5BrCl2N2 | 146533-41-7 | Details |
| Perindopril related compound 3 hydrochloride | C9H16ClNO2 | 169061-41-0 | Details |
| 5-Bromo-2-chloropyrimidine | C4H2BrClN2 | 32779-36-5 | Details |
| Xanomeline Impurity 4 | C12H17N3O3S | 159058-46-5 | Details |
| Xanomeline Impurity 11 | C7H6N2O | 17604-74-9 | Details |
| Triacetic Acid Impurity 3 | C8H13N3O7 | 862542-34-5 | Details |
| Cyclopenta[b]pyran-5-heptanoic acid, 2-(1,1-difluoropentyl)octahydro-2-hydroxy-6-oxo-, (2R,4aR,5S,7aR)- | C20H32F2O5 | 1808535-45-6 | Details |
| 5-(4-Bromophenyl)-4-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-6-fluoropyrimidine | C16H11Br2FN4O2 | 1803092-45-6 | Details |
| Candesartan Cilexetil Impurity H | C52H48N6O6 | 170791-09-0 | Details |
| Ethylenediamine reference standard | Details |
| Dolutegravir Impurity K | Details |
| Tadalafil iMpurity 17 | C22H20ClN3O4 | 951661-84-0 | Details |
| Aztreonam E-Isomer | C13H17N5O8S2 | 99341-02-3 | Details |
| Adrenaline Impurity 26（Adrenergic methoxy analogues） | C10H15NO3.ClH | 74571-90-7 | Details |
| Hydrochlorothiazide | C7H8ClN3O4S2 | 58-93-5 | Details |
| Diclofenac sodium | C14H10Cl2NNaO2 | 15307-79-6 | Details |
| 5-Chloro-2,4-dimethylbenzene-1-thiol | C8H9ClS | 1823050-95-8 | Details |
| Lorazepam USP Impurity E | C15H10Cl2N2O | 773871-49-1 | Details |
| 3-Ethylaniline | C8H11N | 587-02-0 | Details |
| Rebamipide reference standard | C19H15ClN2O4 | 90098-04-7 | Details |
| Phentolamine mesilate | C18H23N3O4S | 65-28-1 | Details |
| Lorazepam USP Impurity B | C13H9Cl2NO | 2958-36-3 | Details |
| Vancomycin EP Impurity K | C67H77Cl2N9O24 | 99759-13-4 | Details |
| (S)-4-(3-(Benzylthio)phenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline hydrochloride | C23H22Cl3NS | 2322360-87-0 | Details |
| Xanomeline Impurity 12 | C7H7N3 | 131988-63-1 | Details |
| Carbocisteine Impurity 2 | C5H9NO5S | 5439-87-2 | Details |
| BORIC-10B ACID | BH3O3 | 13813-79-1 | Details |
| Flusulfonamide API-S | C14H13F4N3O3S | 2421252-74-4 | Details |
| 11-Oxo-3β-[[2-O-(6-oxo-β-D-glucopyranosyl)-6-oxo-β-D-glucopyranosyl]oxy]-24-hydroxyolean-12-en-30-oic acid | C42H62O17 | 118441-84-2 | Details |
| 18α-Glycyrrhizic acid | C42H62O16 | 83896-44-0 | Details |
| Deoxyadrenaline hydrochloride | C9H14ClNO2 | 62-32-8 | Details |
| Dolutegravir Impurity G | C20H20FN3O5 | 1863916-88-4 | Details |
| D65-B interconversion impurity | C18H16F2N2O6 | 1646862-09-0 | Details |
| Cefazolin Impurity J | C13H14N6O6S | 32510-61-5 | Details |
| Carcassone oxide | C25H31F3O6S | 948566-13-0 | Details |
| 4- (1-Nitrosylhydrazido) - benzenesulfonamide | C6H8N4O3S | 2860553-70-2 | Details |
| Xanomeline Impurity 2 | C13H21N3OS | 131986-96-4 | Details |
| Rocuronium Bromide Impurity 34 | C27H46N2O2 | 144209-33-6 | Details |
| Dehydro Desloratadine | C19H17ClN2 | 117811-20-8 | Details |
| Glucose acid impurity 6 | C18H14FIS | 2436275-39-5 | Details |
| Dolutegravir Impurity C | C20H21N3O5 | 2244161-71-3 | Details |
| Sodium 6-hydroxynaphthalene-2-sulfonate | C10H7NaO4S | 135-76-2 | Details |
| Vancomycin Impurity E | Details |
| 2(5H)-Furanone, 3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)-, (5R)- | C14H11F5O3 | 2875066-35-4 | Details |
| Micammonium chloride reference substance | Details |
| Amlodipine Impurity C | C22H30ClN3O6 | 721958-74-3 | Details |
| Vancomycin Impurity B | 555598-85-1 | Details |
| Lorazepam USP Impurity C | C15H8Cl2N2O | 93955-15-8 | Details |
| Tenapanor hydrochloride | C50H68Cl6N8O10S2 | 1234365-97-9 | Details |
| opromide Impurity F | C21H28I3N3O9 | 154361-54-3 | Details |
| Diazoxide reference substance (main component) | C8H7ClN2O2S | 364-98-7 | Details |
| Polydocanol working reference standard | C30H62O10 | 3055-99-0 | Details |
| Dolutegravir Impurity F | C20H19F2N3O5 | 2244161-72-4 | Details |
| Faropenem finished product impurity 3 | C12H17NO6S | 774505-06-5 | Details |
| D-Carnitine | C7H15NO3 | 541-14-0 | Details |
| Ipratropium Bromide Impurity 6 | C20H30BrNO3 | 60251-88-9 | Details |
| Pyrimidine, 5-(4-bromophenyl)-4-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-6-chloro- | C16H11Br2ClN4O2 | 1642873-05-9 | Details |
| Vancomycin Impurity J | C66H75Cl2N9O24 | 2416251-24-4 | Details |
| Xanomeline Impurity 14 | 131988-19-7 | Details |
| Fluticasone Propionate Impurity 100 | C42H50F4O8S | 2408725-66-4 | Details |
| Faropenem finished product impurity 6 | Details |
| Famotidine Impurity D | C8H13N5OS2 | 76824-16-3 | Details |
| Vancomycin Impurity D | Details |
| Dolutegravir Impurity L | C27H25F2N3O5 | 1206102-11-5 | Details |
| Intermediate of tenapanor | C50H66Cl4N8O10S2 | 1234423-95-0 | Details |
| Palonosetron hydrochloride impurity B | Details |
| Famotidine Impurity A | C8H15N7O2S3 | 88061-72-7 | Details |
| Vortioxetine Impurity 54 | C16H18N2S | 1293489-64-1 | Details |
| Dolutegravir Impurity D | C20H20FN3O5 | 1863916-87-3 | Details |
| Aztreonam Impurity 1 | Details |
| Lorazepam USP Impurity D | C15H8Cl2N2O2 | 54643-79-7 | Details |
| Vancomycin Impurity M | C67H77Cl2N9O24 | 250273-66-6 | Details |
| Glucose acid impurity 12 | C18H42O6Si4 | 2348-31-4 | Details |
| Lorazepam EP Impurity D | C15H10Cl2N2O2 | 54699-91-1 | Details |
| Faropenem finished product impurity 4 | C8H9NO3S | 613670-77-2 | Details |
| Lorazepam EP Impurity C | C15H10Cl2N2O2 | 2955-37-5 | Details |
| Sodium 7-hydroxy-1,3,6-naphthalene trisulfonate | C10H5Na3O10S3 | 53683-45-7 | Details |
| Disodium 7-hydroxy-1,3-naphthalenedisulfonate | C10H9NaO7S2 | 842-19-3 | Details |
| Product Total： Product Page： | ||||
| 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 | ||||